Stay updated on Leflunomide+Vemurafenib in V600 Met. Melanoma Clinical Trial
Sign up to get notified when there's something new on the Leflunomide+Vemurafenib in V600 Met. Melanoma Clinical Trial page.

Latest updates to the Leflunomide+Vemurafenib in V600 Met. Melanoma Clinical Trial page
- Check4 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a Locations section listing the study sites in Massachusetts. Removed the older Massachusetts Locations reference and the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check40 days agoChange DetectedAdded Melanoma as a related topic and added MedlinePlus Genetics as a related topic on the study page.SummaryDifference0.2%

- Check47 days agoChange DetectedRevision: v3.3.2 was added; Melanoma and related topics (including MedlinePlus Genetics) and Revision: v3.3.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page shows a minor metadata revision, updating the page revision from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedNotice about government funding and NIH operating status has been removed. No trial details, eligibility criteria, or study results are affected.SummaryDifference0.4%

Stay in the know with updates to Leflunomide+Vemurafenib in V600 Met. Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Leflunomide+Vemurafenib in V600 Met. Melanoma Clinical Trial page.